Evidence map›Paper›PMID 38600620›Full record

ArticleJournal of the American Geriatrics Society2024

Central nervous system medication use around hospitalization.

Juliessa M Pavon, Richard J Sloane, Cathleen S Colón-Emeric, Carl F Pieper, Kenneth Schmader, David Gallagher, Susan N Hastings

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Impact of Hospitalizations on Problematic Medication Use Among Community-Dwelling Persons With Dementia.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juliessa M PavonDepartment of Medicine/Division of Geriatrics, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-9047-0051
Richard J SloaneGeriatric Research Education Clinical Center, Durham Veteran Affairs Health Care System, Durham, North Carolina, USA.
Cathleen S Colón-EmericDepartment of Medicine/Division of Geriatrics, Duke University, Durham, North Carolina, USA.
Carl F PieperCenter for the Study of Aging and Human Development, Duke University, Durham, North Carolina, USA.
Kenneth SchmaderDepartment of Medicine/Division of Geriatrics, Duke University, Durham, North Carolina, USA.
David GallagherDepartment of Medicine/Division of General Internal Medicine/Hospital Medicine, Duke University, Durham, North Carolina, USA.
Susan N HastingsDepartment of Medicine/Division of Geriatrics, Duke University, Durham, North Carolina, USA.

Funding

Deprescribing Central Nervous System Medications in Hospitalized Older AdultsK23AG058788 · NIA · DUKE UNIVERSITY · PI PAVON, JULIESSA M · 2019 to 2023
$797k
Doris Duke Charitable Foundation 2015207NIA NIH HHS AG058788-01A1NIA NIH HHS K23 AG058788
6 · The paper itself

Abstract

backgroundCentral nervous system (CNS) medication use is common among older adults, yet the impact of hospitalizations on use remains unclear. This study details CNS medication use, discontinuations, and user profiles during hospitalization periods.

methodsRetrospective cohort study using electronic health records on patients ≥65 years, from three hospitals (2018-2020), and prescribed a CNS medication around hospitalization (90 days prior to 90 days after). Latent class transitions analysis (LCTA) examined profiles of CNS medication class users across four time points (90 days prior, admission, discharge, 90 days after hospitalization).

resultsAmong 4666 patients (mean age 74.3 ± 9.3 years; 63% female; 70% White; mean length of stay 4.6 ± 5.6 days (median 3.0 [2.0, 6.0]), the most commonly prescribed CNS medications were antidepressants (56%) and opioids (49%). Overall, 74% (n = 3446) of patients were persistent users of a CNS medication across all four time points; 7% (n = 388) had discontinuations during hospitalization, but of these, 64% (216/388) had new starts or restarts within 90 days after hospitalization. LCTA identified three profile groups: (1) low CNS medication users, 54%-60% of patients; (2) mental health medication users, 30%-36%; and (3) acute/chronic pain medication users, 9%-10%. Probability of staying in same group across the four time points was high (0.88-1.00). Transitioning to the low CNS medication use group was highest from admission to discharge (probability of 9% for pain medication users, 5% for mental health medication users). Female gender increased (OR 2.4, 95% CI 1.3-4.3), while chronic kidney disease lowered (OR 0.5, 0.2-0.9) the odds of transitioning to the low CNS medication use profile between admission and discharge.

conclusionsCNS medication use stays consistent around hospitalization, with discontinuation more likely between admission and discharge, especially among pain medication users. Further research on patient outcomes is needed to understand the benefits and harms of hospital deprescribing, particularly for medications requiring gradual tapering.

Indexed as

Central Nervous System AgentsHospitalizationAgedAged, 80 and overAnalgesics, OpioidAntidepressive AgentsElectronic Health RecordsFemaleHumansLength of StayMalePatient DischargeRetrospective StudiesAnalgesics, OpioidAntidepressive AgentsCentral Nervous System Agentscentral nervous system medicationsdeprescribingelectronic health recordshospitalolder adults

Identifiers

PMID38600620
PMCPMC11187667

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.